Quick Overview: Burcu Zeydan, MD, Mayo Clinic, Rochester, MN, talks about her Jiwon Oh, MD, PhD, St. Michael's Hospital, University of Toronto, Toronto, Canada, Jeffrey A. Cohen, MD, Cleveland Clinic, Cleveland, OH, comments on exciting topics discussed during the first day of the ...

Highlights From Actrims Comorbidities Paramagnetic - Detailed Overview & Context

Burcu Zeydan, MD, Mayo Clinic, Rochester, MN, talks about her Jiwon Oh, MD, PhD, St. Michael's Hospital, University of Toronto, Toronto, Canada, Jeffrey A. Cohen, MD, Cleveland Clinic, Cleveland, OH, comments on exciting topics discussed during the first day of the ... Barry Singer, MD, The MS Center for Innovations in Care, St. Louis, MO, shares key insights from the annual This year, the largest MS scientific conference in the world went virtual to share the latest findings and progress in MS with over ... The seventh annual Americas Committee for Treatment and Research in Multiple Sclerosis (

A subset of chronic active white matter lesions in multiple sclerosis (MS) are known as ... over time through various complicated data analysis approaches to mri and then In this video interview, Kaitlyn Palmer, MD, a neuroimmunology fellow at the Cleveland Clinic, reflected on the 2026 Kristine Werner Ozug lives with MS and, full disclosure, she's a member of the RealTalk MS team. After the In episode 2, Clyde E. Markowitz, MD, reviews data released at the Dr. Christina Azevedo is an Associate Professor of Neurology at the University of Southern California. At the

Dr. Mikael Simons is a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative ... Alberto Calvi, MD, PhD Candidate, UCL Queen Square Institute of Neurology, Barts Health NHS Trust, London, UK, explains the ...

Photo Gallery

Highlights from ACTRIMS: comorbidities & paramagnetic rim lesions in MS
Paramagnetic rim lesions in multiple sclerosis
ACTRIMS day 1 highlights with Jeffrey Cohen
Highlights from ACTRIMS 2024
ACTRIMS-ECTRIMS Conference 2020 Highlights
ACTRIMS research priorities
Targeting paramagnetic rim lesions in multiple sclerosis
Drs. Bar-Or and Reich discuss the latest in #multiplesclerosis from #ACTRIMS: https://bit.ly/3Ca5dgp
Exploring ‘MS at a Crossroads’ Theme at the 2026 ACTRIMS Forum
ACTRIMS 2025: A Patient's Perspective with Kristine Werner Ozug
ACTRIMS 2020 News Network: 6-Year Data With Ocrelizumab
Dr Martina Absinta - Using paramagnetic rim lesions in proof-of-concept clinical trials
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored